The Regulator

774.8 billion dollars: that is what the Centers for Medicare and Medicaid Services itself projects a Medicaid rule will save the government over the next decade, and today is the deadline for the public to weigh in before it can become final. The comment period on CMS-2449-P, the Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments proposed rule, closes today, July 21, 2026. Proposed May 20, 2026 to implement Section 71116 of this year’s federal tax and spending law, the rule would cap Medicaid managed care “state directed payments” to providers at 100 percent of the published Medicare rate in Medicaid-expansion states and 110 percent in non-expansion states, eliminate the existing “average commercial rate” ceiling, ban uniform percentage-increase payment arrangements, and phase down existing above-cap payments 10 percentage points a year starting January 1, 2028. CMS projects 774.8 billion dollars in total savings over 10 years, split roughly 510.1 billion dollars federal and 264.4 billion dollars state, money that currently flows largely to hospitals and Medicaid managed care organizations in states that have used the payments to supplement provider reimbursement above standard Medicaid rates. Confidence: High on the rule’s provisions, today’s deadline, and CMS’s own savings projection, since the Federal Register notice and CMS’s press release both confirm them; Low on what survives into a final rule, since the comment period has only just closed. Sources: Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments, Federal Register, CMS Moves to Rein In Misused Medicaid Dollars and Reward Quality Care, Centers for Medicare and Medicaid Services.

A national reference laboratory agreed to pay 9.8 million dollars after turning itself in for paying doctors’ offices to send it business. NeoGenomics Laboratories disclosed in a securities filing dated July 20, 2026 that it will pay 9,813,260 dollars, plus interest accruing since January 16, 2026, to resolve civil False Claims Act liability tied to its “Laboratory Collaboration Initiative,” under which the government alleged the company gave healthcare providers below-market-value consulting services and paid independent consultants variable, referral-based commissions to identify providers who could refer lab-testing business to NeoGenomics, potentially violating the Anti-Kickback Statute and Stark Law. NeoGenomics voluntarily disclosed the arrangement to HHS’s Office of Inspector General in November 2021 and says it has since ended the consulting agreements and terminated the employees responsible; the settlement is not an admission of liability. Confidence: dropped, since the Department of Justice’s own settlement announcement could not be located as of this writing; this account rests on NeoGenomics’ own securities filing describing a settlement with DOJ’s Civil Division and HHS’s Office of Inspector General. Source: NeoGenomics, Inc. Form 8-K, U.S. Securities and Exchange Commission.

An air ambulance company got its day in federal court today arguing that insurers cannot simply ignore a No Surprises Act arbitration award once they lose it. A judge in the U.S. District Court for the Northern District of Illinois heard oral argument today, July 21, 2026, on Health Care Services Corporation’s motion to dismiss a suit brought by air-ambulance provider PHI Health, which accuses the Blue Cross Blue Shield insurer of withholding or delaying payment after losing a No Surprises Act independent dispute resolution arbitration, in violation of the No Surprises Act itself, the Federal Arbitration Act, the Employee Retirement Income Security Act, and Illinois consumer-protection law. The case, before Judge Matthew Kennelly, is one of a growing number nationally testing whether providers can actually force payment when an insurer loses arbitration under the two-year-old law, since the statute created a process to set the price but no explicit federal mechanism to make insurers pay what they owe. Confidence: Medium, since today’s argument addressed only whether the case proceeds and no ruling has been issued. Source: PHI Health, LLC v. Health Care Services Corporation, Health Care Litigation Tracker, Georgetown University O’Neill Institute.

The Food and Drug Administration admitted the lab test that pointed investigators to Taco Bell’s lettuce supplier in a multistate cyclospora outbreak was wrong, but the recall stays in place anyway. FDA said Sunday, July 19, 2026 that a lettuce sample it had reported as testing positive for Cyclospora, the parasite behind an outbreak that had sickened at least 1,644 people and hospitalized 94 across five states as of the agency’s last confirmed count, was actually a false positive; FDA laboratory experts re-reviewed the sample and concluded the result did not represent true genetic amplification. The agency said the retraction does not change its underlying traceback conclusion or the recall of central-Mexico-sourced iceberg lettuce from supplier Taylor Farms de Mexico, since Cyclospora is notoriously difficult to culture directly from food and the epidemiological and traceback evidence behind the recall stands independent of the retracted lab result. Confidence: Medium on the retraction itself, since it rests on FDA’s own statement as reported by multiple outlets; Low on what happens next, since FDA has not named a confirmed alternative source and the case-count figures above reflect the agency’s last independently confirmed update rather than a fresh count. Sources: Investigation of 5-State Outbreak of Cyclospora Illnesses: Iceberg Lettuce, U.S. Food and Drug Administration, FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test, NPR.

Tennessee just closed the application window on its slice of a 50 billion dollar federal rural health fund, and rural hospitals now wait to find out who gets paid. The Tennessee Department of Health closed intake July 20, 2026 on its first wave of Rural Health Transformation Program grant opportunities, including a Memory Care Assessment Network award and five statewide requests for proposals covering an eConsult platform, a nurse call center, rural non-emergency transportation, a maternal-health mobile app, and a rural health innovation catalyst. Tennessee received approximately 206.9 million dollars in Budget Period 1 funding under the federal Rural Health Transformation Program, a five-year, 50 billion dollar fund created by this year’s federal tax and spending law to shore up rural hospitals and health systems nationwide; eligible rural hospitals, federally qualified health centers, and nonprofits now wait for the state to announce which applicants get funded, the next concrete milestone in a rollout every state is running on its own timeline. Confidence: Medium-High on the dollar figure and deadline, corroborated across the state health department’s own program pages; Low on award timing, since Tennessee has not published a decision date. Sources: Rural Health Transformation Program, Tennessee Department of Health, Procurement Opportunities, Tennessee Department of Health.